1. Vemurafenib reverses immunosuppression by myeloid derived suppressor cells. Issue 7 (13th April 2013) Authors: Schilling, Bastian; Sucker, Antje; Griewank, Klaus; Zhao, Fang; Weide, Benjamin; Görgens, André; Giebel, Bernd; Schadendorf, Dirk; Paschen, Annette Journal: International journal of cancer Issue: Volume 133:Issue 7(2013:Oct. 01) Page Start: 1653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors. (1st February 2018) Authors: López-Cobo, Sheila; Pieper, Natalia; Campos-Silva, Carmen; García-Cuesta, Eva M.; Reyburn, Hugh T.; Paschen, Annette; Valés-Gómez, Mar Journal: Oncoimmunology Issue: Volume 7:Number 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors. (December 2021) Authors: Thielmann, Carl M.; Chorti, Eleftheria; Matull, Johanna; Murali, Rajmohan; Zaremba, Anne; Lodde, Georg; Jansen, Philipp; Richter, Luisa; Kretz, Julia; Möller, Inga; Sucker, Antje; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; ... Journal: European journal of cancer Issue: Volume 159(2021) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy. (January 2022) Authors: Thielmann, Carl M.; Matull, Johanna; Zaremba, Anne; Murali, Rajmohan; Chorti, Eleftheria; Lodde, Georg; Jansen, Philipp; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Ulrich, Jens; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Dippel, Edgar; Weichentha... Journal: European journal of cancer Issue: Volume 161(2022) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma. (May 2016) Authors: Roesch, Alexander; Paschen, Annette; Landsberg, Jenny; Helfrich, Iris; Becker, Jürgen C.; Schadendorf, Dirk Journal: European journal of cancer Issue: Volume 59(2016) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ER‐aminopeptidase 1 determines the processing and presentation of an immunotherapy‐relevant melanoma epitope. Issue 2 (27th November 2019) Authors: Textoris‐Taube, Kathrin; Cammann, Clemens; Henklein, Petra; Topfstedt, Eylin; Ebstein, Frédéric; Henze, Sarah; Liepe, Juliane; Zhao, Fang; Schadendorf, Dirk; Dahlmann, Burkhardt; Uckert, Wolfgang; Paschen, Annette; Mishto, Michele; Seifert, Ulrike Journal: European journal of immunology Issue: Volume 50:Issue 2(2020) Page Start: 270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype. Issue 11 (1st November 2022) Authors: Albrecht, Lea Jessica; Höwner, Anna; Griewank, Klaus; Lueong, Smiths S.; von Neuhoff, Nils; Horn, Peter A.; Sucker, Antje; Paschen, Annette; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Horn, Susanne; Siveke, Jens T.; Schadendorf, Dirk; Váraljai, Renáta; Roesch, Alexander Journal: Clinical and translational medicine Issue: Volume 12:Issue 11(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors. Issue 9 (11th July 2022) Authors: Zaremba, Anne; Jansen, Philipp; Murali, Rajmohan; Mayakonda, Anand; Riedel, Anna; Philip, Manuel; Rose, Christian; Schaller, Jörg; Müller, Hansgeorg; Kutzner, Heinz; Möller, Inga; Stadtler, Nadine; Kretz, Julia; Sucker, Antje; Bankfalvi, Agnes; Livingstone, Elisabeth; Zimmer, Lisa; Horn, Susanne;... Journal: International journal of cancer Issue: Volume 151:Issue 9(2022) Page Start: 1542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity. Issue 6 (13th June 2022) Authors: Thier, Beatrice; Zhao, Fang; Stupia, Simone; Brüggemann, Alicia; Koch, Johannes; Schulze, Nina; Horn, Susanne; Coch, Christoph; Hartmann, Gunther; Sucker, Antje; Schadendorf, Dirk; Paschen, Annette Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Direct RIG‐I activation in human NK cells induces TRAIL‐dependent cytotoxicity toward autologous melanoma cells. Issue 7 (9th January 2019) Authors: Daßler‐Plenker, Juliane; Paschen, Annette; Putschli, Bastian; Rattay, Stephanie; Schmitz, Saskia; Goldeck, Marion; Bartok, Eva; Hartmann, Gunther; Coch, Christoph Journal: International journal of cancer Issue: Volume 144:Issue 7(2019) Page Start: 1645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗